Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Use of (2R, 6R)-hydroxynorketamine, (S)-dehydronorketamine and other stereoisomeric dehydro and hydroxylated metabolites of (R,S)-ketamine in the treatment of depression and neuropathic pain

US Patent 9650352 · Granted May 16, 2017

Assignee

Inventors

View full patent text on Google Patents →